Phenoxyacetic acid scaffold as a platform for dual anticonvulsant and anti-inflammatory drug design | Synapse
April 12, 2026
Phenoxyacetic acid scaffold as a platform for dual anticonvulsant and anti-inflammatory drug design
Puntos clave
The research aims to explore the development of drugs that address both anticonvulsant and anti-inflammatory effects to improve epilepsy treatment.
Identified phenoxyacetic acid as a scaffold for drug design
Assessed compounds for anticonvulsant activity
Evaluated potential anti-inflammatory properties
Investigated mechanisms related to neuroinflammation and epilepsy
Dual-action compounds showed promise in reducing seizures
Anti-inflammatory effects noted in experimental models
Enhanced efficacy observed compared to single-action drugs
Resumen
Neuroinflammation is increasingly recognized as a critical contributor to epileptogenesis and antiepileptic drug resistance, emphasizing the need for multi-target therapeutic strategies.